A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid in the Stomach in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes Mellitus (opens ClinicalTrials.gov)
- Sponsor
- Eli Lilly and Company
- Enrolment
- 40
- Started
- 2026-01-14
- Last update
- 2026-05-19
Conditions: Diabetes Mellitus, Type 2, Overweight, Obesity
Interventions: Tirzepatide